GARRETT S. LEVIN, M.D. DEPARTMENT OF PEDIATRICS DIVISION OF NEONATOLOGY APNEA OFPREMATURITY APNEA OF PREMATURITY.

Slides:



Advertisements
Similar presentations
 may be efective in preventing SGA birth in women at high risk of preeclampsia although the effect size is small. (c)
Advertisements

Improving Oxygenation
Acute Respiratory Distress Syndrome(ARDS)
CPAP Respiratory therapy EMT-B. CPAP Overview  Applies continuous pressure to airways to improve oxygenation.  Bridge device to improve oxygenation.
Pediatric Fundamentals Prematurity Drs. Greg and Joy Loy Gordon January 2005.
Mechanical Ventilation in the Neonate RC 290 CPAP Indications: Refractory Hypoxemia –PaO2 –Many hospitals use 50% as the upper limit before changing.
Epilepsy 2 Dr. Hawar A. Mykhan.
Chapter 8—Caffeine & Nicotine Robert M. Julien Presentation By: Tamyra Frazier & Sarah Massamore.
Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 8 Xanthines.
1 Copyright © 2012, 2008, 2002, 1998, 1994, 1989, 1984, 1978 by Mosby, Inc., an affiliate of Elsevier Inc. Reminder:  QUIZ NEXT WEEK ON:  Anti-infectives,
Severe Sepsis Initial recognition and resuscitation
Sepsis.
Respiratory Distress Syndrome
Care of Patients with Shock
Patent Ductus Ateriosis PDA Muhammad Syed MD Heart.
Necrotizing Enterocolitis
V Vickers 2002 APNEA, ALTE, and SIDS Valerie Vickers RNC Apnea Program Coordinator, UMC.
Neonatal Resuscitation
Ventilator.
Pediatric Prehospital Seizure Management: Evidence Based Guidelines and State of Care in CO Kathleen Adelgais, MD MPH Pediatric Emergency Medicine Children’s.
Part 5 Control of Respiration
RESPIRATORY DISTRESS SYNDROME
SLEEP STUDIES Written by: Melissa Dearing - LSC-Kingwood.
Respiratory Regulation During Exercise
Ventilation / Ventilation Control Tests
Neonatal emergencies Dr. Miada Mahmoud Rady.
Part I: Noninvasive Positive Pressure Ventilation in the Acute Care Facility By: Susan P. Pilbeam, MS, RRT, FAARC John D. Hiser, MEd, RRT, FAARC Ray Ritz,
Dr Chaitanya Vemuri Int.Med M.D Trainee.  The choice of ventilator settings – guided by clearly defined therapeutic end points.  In most of cases :
M.Noori-Shadkam, MD-MPH Neonatologist. Cessation of airflow for at least 20 seconds or accompanied by bradycardia or cyanosis. Bradycardia and cyanosis.
Complications of Prematurity. Neonatal mortality Causes of neonatal death in Cambridge Maternity Hospital Respiratory distress syndrome137*38.
بسم الله الرحمن الرحيم Prepared by: Ala ’ Qa ’ dan Supervisor :mis mahdia alkaunee Cor pulmonale.
Neonatal Resuscitation
CPAP Murila fv. Respiratory distress syndrome 28% of neonatal deaths are due to prematurity The most common respiratory disorder in the preterm is Respiratory.
Pediatric Sleep-Disordered Breathing
Nadeen mohamed mamdouh Habib
Neonatal Emergencies Dr Ruben Bromiker Department of Neonatology Shaare Zedek Medical Center.
Treating preterm infants with Surfactant: an overview of application techniques and results Angela Kribs, Children‘s Hospital, University of Cologne.
Congenital Heart Disease in Children Dr. Sara Mitchell January
Newborn and Early Childhood Respiratory Disorders RT 265 Chapter 33.
Neonatal Sepsis Islamic University Nursing College.
Inguinal Hernia of Premature Infants
Preterm labor.
Neonatal A & P RC 290. Neonate Compared to Adult  More compliant and flexible thorax  Large tongue  Large U-shaped epiglottis  Narrowest part of upper.
Fluid and Electrolyte Imbalance
Section 4 Regulation of the Respiration.
Respiratory Distress Syndrome (RDS)
Nonatology: Neonatal Respiratory Distress Lecture Points Neonatal pulmonary function Clinical Manifestation The main causes Main types of the disease.
Respiratory Distress Syndrome Hyaline Membrane Disease
The Child with a Cardiovascular Disorder
Apparent Life- Threatening Event K. Myra Lalas, MD 7/1.
ROP. What is ROP  Retinopathy of prematurity (ROP) is a potentially blinding eye disorder that primarily affects premature infants weighing about 2¾.
Bronchiolitis Abdullah M. Al-Olayan MBBS, SBP, ABP. Assistant Professor of Pediatrics. Pediatric Pulmonologist.
3 nd LECTURE VENTILATORS Part One. Ventilators One of the major life support systems. Ventilators take over the vital role of the respiratory muscles.
Dr. Miada Mahmoud Rady EMS /481 Neonatal emergencies
Apnea of prematurity – Introduction and management with Caffeine Harish Narayanan MD Surgery Intern – R1 Seattle Children’s Hospital 07/10/2014.
Asthma 1 د. ميريانا البيضة. DIAGNOSIS 2 3 Definition of asthma.
و قل رب زدني علما صدق الله العظيم. سورة طه آية 114.
Principles of Mechanical Ventilation Mazen Kherallah, M.D., FCCP Internal Medicine, Critical Care Medicine, and Infectious Diseases Initial Ventilatory.
Anemia of Prematurity.
M.Noori-Shadkam, MD-MPH Neonatologist
Resuscitation of The Newborn Baby Lec
RSTH 421 Perinatal & Pediatric Respiratory Care Apnea of Prematurity
RESPIRATORY DISTRESS SYNDROME IN NEONATES
DEFINITION Respiratory problem in premature babies
Resuscitation of The Newborn Baby
BIRTH ASPHYXIA Lec
Resuscitation of The Newborn Baby
Hyaline Membrane Disease
CNS Stimulants: Action #1
Presentation transcript:

GARRETT S. LEVIN, M.D. DEPARTMENT OF PEDIATRICS DIVISION OF NEONATOLOGY APNEA OFPREMATURITY APNEA OF PREMATURITY

Definition of Apnea Apnea is the most common problem of ventilatory control in the premature infant frequently prolonging hospitalization and the need for cardiopulmonary monitoring. The standard definition of apnea is cessation of inspiratory gas flow for 20 seconds, or for a shorter period of time if accompanied by bradycardia (heart rate less than 100 beats per minute), cyanosis, or pallor.

Incidence of Apnea versus Gestational Age Although there is considerable variation in incidence and severity of apnea in premature infants, both are inversely related to gestational age. Approximately 50% of infants less than 1500 grams birth weight require either pharmacologic intervention or ventilatory support for recurrent prolonged apneic episodes. The peak incidence occurs between 5 and 7 days postnatal age. Apnea of Prematurity is a specific diagnosis and usually resolves between 34 to 36 weeks postconceptual age. ONSET USUALLY BY THIRD DAY OF LIFE!

The more hypoxic, the flatter the response to carbon dioxide.

Proposed Pathogenic Mechanisms of Apnea Primary central respiratory center depression Decreased or inhibitory upper afferent input to the central respiratory center Abnormal or hyperactive reflexes Decreased or inhibitory lower afferent input to the central respiratory center Hypoxemia

Primary central respiratory center depression - likely to result in central apnea Fewer neuronal synapses Decreased carbon dioxide (CO2) sensitivity Decreased neurotransmitter levels Metabolic disorders Sepsis Suppression by drugs Decreased or inhibitory upper afferent input to the central respiratory center - likely to result in obstructive, central, or mixed apnea Less cortical traffic Sleep state, especially REM sleep Seizures Metabolic disorders Sepsis Suppression by drugs

Abnormal or hyperactive reflexes - likely to result in central apnea Head's paradoxical reflex (gasp and apnea following lung inflation) Laryngeal receptors (taste buds) acting through superior laryngeal nerves Posterior pharyngeal reflex (apnea induced by deep repeated suctioning) Vascular receptors (apnea induced by large vessel distension) Decreased or inhibitory lower afferent input to the central respiratory center - likely to result in central apnea Sensory receptors (temperature receptors on face) Chemoreceptor immaturity Hypoxemia - likely to result in central or mixed apnea Immature ventilatory response to hypoxemia Presence of lung disease Decreased lung volume Patent ductus arteriosus Anemia Hypotension with decreased oxygen delivery to the brain

Physiologic Effects of Apnea Decrease in arterial oxygen tension Decrease in heart rate Decrease in peripheral blood flow EEG changes suggesting CNS depression if apnea is severe Increase in venous pressure Decrease in muscle tone

Diseases Associated with Apnea Apnea is only a symptom and frequently occurs secondary to other disease processes. However, 'Apnea of Prematurity' is a specific diagnosis and also one of exclusion. Other causes of apneic spells should be pursued if the apnea progresses in severity, fails to respond to appropriate therapy, severe episodes occur on the first day of life, or it appears at a gestational age where it should not occur. Apnea should be treated with simultaneous attention focused on the primary disease. Treatment of these associated problems may result in a decrease in the frequency and severity of apneic spells. These causes include: Respiratory Distress Syndrome Pulmonary mechanical problems such as Airleak, or Atelectasis Infectious causes such as Sepsis, Meningitis, or Pneumonia Intracranial Hemorrhage Seizures Anemia Gastroesophageal Reflux Necrotizing Enterocolitis Patent Ductus Arteriosus Hemorrhagic Shock Metabolic disturbances such as Hypoglycemia, Acidosis, Hyponatremia, Hypocalcemia Maternal Drugs Inappropriate Thermal Environment - Hyperthermia

Types of Apnea Apnea has been classified into three types depending on whether inspiratory muscle activity is present. If inspiratory muscle activity fails following an exhalation, it is termed Central Apnea. If inspiratory muscle activity is present without airflow, this is termed Obstructive Apnea.If both central and obstructive apnea occur during the same episode, this is termed Mixed Apnea. It is important to characterize a patient's apnea episodes into one or more types for treatment consideration.

Principles of Therapy for Apnea of Prematurity Therapy for Apnea of Prematurity can be divided arbitrarily into four groupings based on proposed pathogenic mechanisms that might result in apnea. Institution of interventions should occur in the order of increasing invasiveness and risk. Debate regarding risk of interventions persists, some authors advocating use of methylxanthines prior to CPAP therapy. Increase Afferent Input into the Respiratory Centers Cutaneous or vestibular stimulation Avoid hyperoxia Treatment of Primary Depression of Respiratory Center Treat infection Correct metabolic disturbances Administer central nervous system stimulants (aminophylline, theophylline, caffeine, doxapram)

Treatment of Hypoxemia Treat HMD, pneumonia,aspiration, etc. Increase inspired oxygen Apply continuous positive airway pressure (CPAP) Prone positioning Treat congestive heart failure Close patent ductus arteriosus Transfuse with packed red blood cells Avoidance of Triggering Reflexes Beware of suction catheters Avoid nipple feedings (feed by tube or intravenously) Avoid hyperinflation and hyperventilation during bagging Avoid cold stimuli to the face Place infant in the prone position Avoid severe flexion of neck Treat gastroesophageal reflux

Suggested Treatment Protocol for Apnea of Prematurity Institution of interventions should occur in the order of increasing invasiveness and risk. 1.Diagnose and treat precipitating causes respiratory diseases hypotension sepsis anemia hypoglycemia 2.Initiate stimulation (cutaneous, vestibular) 3.Initiate a trial of nasal prong air/oxygen airflow 4.Initiate a trial of low-pressure nasal continuous positive airway pressure (CPAP) 5.Initiate methylxanthine therapy 6.Initiate mechanical ventilation

When to Initiate a CPAP Trial Apnea that continues in spite of optimum methylxanthine treatment may respond to low level CPAP. Accordingly, a trial of CPAP (4-5 cmH2O) is warranted in addition to or as an alternative to ineffective methylxanthine treatment. Frequent apnea associated with marked bradycardia and/or arterial oxygen desaturation refractory to methylxanthines and/or CPAP should be treated with positive pressure ventilation.

Methylxanthine Therapy The exact mechanism by which methylxanthines exert their beneficial effect in apnea is not known. Proposed mechanisms include increased respiratory drive secondary to increased carbon dioxide sensitivity and increased oxygen consumption. Other mechanisms postulated include adenosine antagonism, enhanced diaphragmatic contractility, and increased cyclic 3', 5' -cyclic AMP. Desaturation spells not associated with apnea are not benefited by methylxanthine therapy. Caffeine is recommended over aminophylline due to it's wider margin of safety and ease of administration (once daily).

Initiation of Methylxanthines Apnea Type Type of InterventionTreatment Indication Spontan eous No intervention required Frequent episodes associated with desaturations (SaO2 <80%) and/or bradycardia (HR <90); e.g., one or more per hour over a long period of time such as hours Mild Light touch, stroke back Associated with desaturations <80% and bradycardia <90 Multiple episodes; more than 6 over a 12 hour period or 12 over a 24 hour period Moderate Move infant, i.e. roll over, reposition, etc. Oxygen administered More than 2 episodes in a 24 hour period Severe Prolonged vigorous stimulation PPV with or without oxygen More than 1 episode in a 24 hour period Note: Apnea, bradycardia, and/or cyanotic spells associated with feeding, handling,suctioning,mucus plugging, etc. should not be counted when determining whether to initiate methylxanthine therapy.

Methylxanthine Dosing Guidelines Caffeine: 10mg/kg IV or PO loading dose of caffeine base (20mg/kg caffeine citrate) of 20 mg/mL solution, then 2.5 mg/kg in one daily dose. Plasma level 8-20 micrograms/mL. Mean caffeine half-life in low birth weight infants hours. Aminophylline: 5 mg/kg IV loading dose, then 1-2 mg/kg IV q8-12 hours: Metabolized to theophylline. Plasma level (theophylline) 5-15 micrograms/mL Mean half-life in low birth weight infants hours. Reminder-Premature infants metabolize up to 15% of administered theophylline to caffeine. Apparent methylxanthine toxicity can occur despite therapeutic plasma theophylline levels.

Adverse Effects of Methylxanthine Therapy Excessive diuresis Increased cerebral metabolic rate (X2-3) Decreased anoxic survival in animal studies Increased cardiac output Decreased cerebral blood flow Increased blood sugar levels Increased plasma glycerol Increased lung glycogen metabolism Decrease cholesterol synthesis in glial cells Decreased cerebral cell growth and division Decreased retinal blood flow

References Miller MJ and Martin RJ. Apnea of Prematurity. Clinics in Perinatology. 19: , Schmidt B. Methylxanthine therapy in premature infants: Sound practice, disaster, or fruitless byway? J Pediatr 135: , Lagercrantz H. What does the preterm infant breathe for? Controversies on apnea of prematurity. Acta Paediatr81: , Bucher HU and Duc G. Does caffiene prevent hypoxaemic episodes in premature infants? Eur J Pediatr 147: , Martin RJ. Neonatal apnea, bradycardia, or desaturation: Does it matter? J Pediatr 132: , National Institutes of Health Concensus Development Conference on Infantile Apnea and Home Monitoring. Pediatrics 79: , 1987.